Why Do People Living with HIV Adhere to Antiretroviral Therapy and Not Comorbid Cardiovascular Disease Medications? A Qualitative Inquiry

References

• Hall HI, Brooks JT, Mermin J. Can the United States achieve 90–90–90? Curr Opin HIV AIDS. 2019;14(6:464–470. doi:10.1097/coh.0000000000000578.
   PubMed Web of Science ®Google Scholar
• UNAIDS. 90-90-90 treatment for all; 2020. Available from: https://www.unaids.org/en/resources/909090. Accessed December 12, 2019.
   Google Scholar
• Nakagawa F, Lodwick RK, Smith CJ, et al. Projected life expectancy of people with HIV according to timing of diagnosis. AIDS. 2012;26:335–343. doi:10.1097/QAD.0b013e32834dcec9
   PubMed Web of Science ®Google Scholar
• Freiberg MS, Chang CC, Kuller LH, et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med. 2013;173:614–622. doi:10.1001/jamainternmed.2013.3728
   PubMed Web of Science ®Google Scholar
• Longenecker CT, Triant VA. Initiation of antiretroviral therapy at high CD4 cell counts: does it reduce the risk of cardiovascular disease? Curr Opin HIV AIDS. 2014;9:54–62. doi:10.1097/coh.0000000000000015
   PubMed Web of Science ®Google Scholar
• De Socio GV, Ricci E, Maggi P, et al. Prevalence, awareness, treatment, and control rate of hypertension in HIV-infected patients: the HIV-HY study. Am J Hypertens. 2013;27:222–228. doi:10.1093/ajh/hpt182
   Web of Science ®Google Scholar
• Burkholder GA, Tamhane AR, Safford MM, et al. Racial disparities in the prevalence and control of hypertension among a cohort of HIV-infected patients in the southeastern United States. PLoS One. 2018;13:e0194940–e0194940. doi:10.1371/journal.pone.0194940
   PubMed Web of Science ®Google Scholar
• Clement ME, Park LP, Navar AM, et al. Statin utilization and recommendations among HIV- and HCV-infected Veterans: a cohort study. Clin Infect Dis. 2016;63:407–413. doi:10.1093/cid/ciw289
   PubMed Web of Science ®Google Scholar
• Burkholder GA, Tamhane AR, Salinas JL, et al. Underutilization of aspirin for primary prevention of cardiovascular disease among HIV-infected patients. Clin Infect Dis. 2012;55:1550–1557. doi:10.1093/cid/cis752
   Web of Science ®Google Scholar
• Monroe AK, Rowe TL, Moore RD, et al. Medication adherence in HIV-positive patients with diabetes or hypertension: a focus group study. BMC Health Serv Res. 2013;13(1):488. doi:10.1186/1472-6963-13-488
   Web of Science ®Google Scholar
• Ho PM, Magid DJ, Shetterly SM, et al. Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease. Am Heart J. 2008;155(4):772–779. doi:10.1016/j.ahj.2007.12.011
   PubMed Web of Science ®Google Scholar
• Gardner EM, McLees MP, Steiner JF, et al. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52(6):793–800. doi:10.1093/cid/ciq243
   PubMed Web of Science ®Google Scholar
• Bangsberg DR. Monitoring adherence to HIV antiretroviral therapy in routine clinical practice: the past, the present, and the future. AIDS Behav. 2006;10(3:249–251. doi:10.1007/s10461-006-9121-7.
   PubMed Web of Science ®Google Scholar
• Croome N, Ahluwalia M, Hughes LD, et al. Patient-reported barriers and facilitators to antiretroviral adherence in sub-Saharan Africa. AIDS. 2017;31(7):995–1007. doi:10.1097/QAD.0000000000001416
   PubMed Web of Science ®Google Scholar
• Langness J, Cook PF, Gill J, et al. Comparison of adherence rates for antiretroviral, blood pressure, or mental health medications for HIV-positive patients at an academic medical center outpatient pharmacy. J Managed Care Pharm. 2014;20(8):809–814. doi:10.18553/jmcp.2014.20.8.809
   Google Scholar
• Batchelder AW, Gonzalez JS, Berg KM. Differential medication nonadherence and illness beliefs in co-morbid HIV and type 2 diabetes. J Behav Med. 2014;37:266–275. doi:10.1007/s10865-012-9486-1
   PubMed Web of Science ®Google Scholar
• Monroe AK, Pena JS, Moore RD, et al. Randomized controlled trial of a pictorial aid intervention for medication adherence among HIV-positive patients with comorbid diabetes or hypertension. AIDS Care. 2018;30:199–206. doi:10.1080/09540121.2017.1360993
   PubMed Web of Science ®Google Scholar
• Weiss JJ, Konstantinidis I, Boueilh A, et al. Illness perceptions, medication beliefs, and adherence to antiretrovirals and medications for comorbidities in adults with HIV infection and hypertension or chronic kidney disease. J Acquired Immune Deficiency Syndromes. 2016;73:403–410. doi:10.1097/qai.0000000000001075
   PubMed Web of Science ®Google Scholar
• Okeke NL, Webel AR, Bosworth HB, et al. Rationale and design of a nurse-led intervention to extend the HIV treatment cascade for cardiovascular disease prevention trial (EXTRA-CVD). Am Heart J. 2019;216:91–101. doi:10.1016/j.ahj.2019.07.005
   PubMed Web of Science ®Google Scholar
• Weiser J, Beer L, Brooks JT, et al. Delivery of HIV antiretroviral therapy adherence support services by HIV care providers in the United States, 2013 to 2014. J Int Assoc Provid AIDS Care. 2017;16:624–631. doi:10.1177/2325957417729754
   Google Scholar
• Thompson MA, Mugavero MJ, Amico KR, et al. Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International association of physicians in AIDS care panel. Ann Intern Med. 2012;156:817–833, w-284, w-285, w-286, w-287, w-288, w-289, w-290, w-291, w-292, w-293, w-294. doi:10.7326/0003-4819-156-11-201206050-00419
   Web of Science ®Google Scholar
• Cioe PA, Crawford SL, Stein MD. Cardiovascular risk-factor knowledge and risk perception among HIV-infected adults. J Assoc Nurses AIDS Care. 2014;25:60–69. doi:10.1016/j.jana.2013.07.006
   PubMed Web of Science ®Google Scholar
• Webel A, Davey CH, Schexnayder J, et al. The impact of perceived cardiovascular risk on cardiovascular disease prevention behaviors in people with and without HIV infection. J Acquired Immune Deficiency Syndromes. 2020. doi:10.1097/qai.0000000000002290
   Web of Science ®Google Scholar
• Elliott RA, Ross-Degnan D, Adams AS, et al. Strategies for coping in a complex world: adherence behavior among older adults with chronic illness. J Gen Intern Med. 2007;22:805–810. doi:10.1007/s11606-007-0193-5
   PubMed Web of Science ®Google Scholar
• Clifford S, Barber N, Horne R. Understanding different beliefs held by adherers, unintentional nonadherers, and intentional nonadherers: application of the necessity-concerns framework. J Psychosom Res. 2008;64:41–46. doi:10.1016/j.jpsychores.2007.05.004
   PubMed Web of Science ®Google Scholar
• Krueger KP, Berger BA, Felkey B. Medication adherence and persistence: a comprehensive review. Adv Ther. 2005;22:313–356. doi:10.1007/bf02850081
   PubMed Web of Science ®Google Scholar
• NHLBI. Implementation research to develop interventions for people living with HIV (preclude) (U01); 2017. Available from: https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-18-007.html. Accessed November 1, 2019.
   Google Scholar
• Gamble-George JC, Longenecker CT, Webel AR, et al. Implementation research to develop interventions for people living with HIV (the preclude consortium): combatting chronic disease comorbidities in HIV populations through implementation research. Prog Cardiovasc Dis. 2020. doi:10.1016/j.pcad.2020.03.006
   Web of Science ®Google Scholar
• Aifah A, Okeke NL, Rentrope CR, et al. Use of a human-centered design approach to adapt a nurse-led cardiovascular disease prevention intervention in HIV clinics. Prog Cardiovasc Dis. 2020. doi:10.1016/j.pcad.2020.02.013
   Web of Science ®Google Scholar
• Palinkas LA, Horwitz SM, Green CA, et al. Purposeful sampling for qualitative data collection and analysis in mixed method implementation research. Adm Policy Ment Health. 2015;42:533–544. doi:10.1007/s10488-013-0528-y
   PubMed Web of Science ®Google Scholar
• Schreier M. Qualitative Content Analysis in Practice. London: Sage; 2012.
   Google Scholar
• Hsieh HF, Shannon SE. Three approaches to qualitative content analysis. Qual Health Res. 2005;15:1277–1288. doi:10.1177/1049732305276687
   PubMed Web of Science ®Google Scholar
• Glaser B, Strauss A. The Discovery of Grounded Theory. London: Weidenfield & Nicolson.; 1967.
   Google Scholar
• software D. Web application for managing, analyzing, and presenting qualitative and mixed method research data; 2019. Available from: https://www.dedoose.com/. Accessed October 30, 2019.
   Google Scholar
• Final NIH policy on the use of a single institutional review board for multi-site research. https://grants.nih.gov/grants/guide/notice-files/NOT-OD-16-094.html. Accessed December 26, 2018.
   Google Scholar
• Roter DL. Patient participation in the patient-provider interaction: the effects of patient question asking on the quality of interaction, satisfaction and compliance. Health Educ Monogr. 1977;5:281–315. doi:10.1177/109019817700500402
   PubMedGoogle Scholar
• Alegría M, Sribney W, Perez D, et al. The role of patient activation on patient-provider communication and quality of care for US and foreign born Latino patients. J Gen Intern Med. 2009;24(Suppl 3):534–541. doi:10.1007/s11606-009-1074-x
   Web of Science ®Google Scholar
• Temu TM, Kirui N, Wanjalla C, et al. Cardiovascular health knowledge and preventive practices in people living with HIV in Kenya. BMC Infect Dis. 2015;15:421. doi:10.1186/s12879-015-1157-8
   PubMed Web of Science ®Google Scholar
• Ogedegbe G, Harrison M, Robbins L, et al. Barriers and facilitators of medication adherence in hypertensive African Americans: a qualitative study. Ethn Dis. 2004;14:3–12.
   PubMed Web of Science ®Google Scholar
• Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487–497. doi:10.1056/NEJMra050100
   PubMed Web of Science ®Google Scholar
• Safren SA, Otto MW, Worth JL, et al. Two strategies to increase adherence to HIV antiretroviral medication: life-steps and medication monitoring. Behav Res Ther. 2001;39:1151–1162. doi:10.1016/s0005-7967(00)00091-7
   PubMed Web of Science ®Google Scholar
• Benson J, Britten N. Patients’ decisions about whether or not to take antihypertensive drugs: qualitative study. BMJ. 2002;325:873. doi:10.1136/bmj.325.7369.873
   PubMed Web of Science ®Google Scholar
• Lamiraud K, Geoffard PY. Therapeutic non-adherence: a rational behavior revealing patient preferences? Health Econ. 2007;16:1185–1204. doi:10.1002/hec.1214
   PubMed Web of Science ®Google Scholar
• AJ C. Patient Adherence to Medical Treatment Regimens: Bridging the Gap Between Behavioral Science and Biomedicine. New Haven, CT: Yale University Press; 2004.
   Google Scholar
• WHO. Global action plan on HIV drug resistance 2017–2021: 2018 progress report; 2018. Available from: https://www.who.int/hiv/pub/drugresistance/gap-hivdr-progress2018/en/. Accessed April 23, 2020.
   Google Scholar